327 related articles for article (PubMed ID: 27622933)
1. Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response.
Li QS; Tian C; Seabrook GR; Drevets WC; Narayan VA
Transl Psychiatry; 2016 Sep; 6(9):e889. PubMed ID: 27622933
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide association studies of antidepressant class response and treatment-resistant depression.
Li QS; Tian C; Hinds D;
Transl Psychiatry; 2020 Oct; 10(1):360. PubMed ID: 33106475
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 17 selectively predicts better outcomes with bupropion-SSRI combination: Novel T cell biomarker for antidepressant medication selection.
Jha MK; Minhajuddin A; Gadad BS; Greer TL; Mayes TL; Trivedi MH
Brain Behav Immun; 2017 Nov; 66():103-110. PubMed ID: 28698115
[TBL] [Abstract][Full Text] [Related]
4. Citalopram and bupropion-SR: combining versus switching in patients with treatment-resistant depression.
Lam RW; Hossie H; Solomons K; Yatham LN
J Clin Psychiatry; 2004 Mar; 65(3):337-40. PubMed ID: 15096072
[TBL] [Abstract][Full Text] [Related]
5. Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance.
Fabbri C; Crisafulli C; Calati R; Albani D; Forloni G; Calabrò M; Martines R; Kasper S; Zohar J; Juven-Wetzler A; Souery D; Montgomery S; Mendlewicz J; Serretti A
Eur Arch Psychiatry Clin Neurosci; 2017 Dec; 267(8):723-735. PubMed ID: 28260126
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of bupropion and the selective serotonin reuptake inhibitors in the treatment of major depressive disorder with high levels of anxiety (anxious depression): a pooled analysis of 10 studies.
Papakostas GI; Stahl SM; Krishen A; Seifert CA; Tucker VL; Goodale EP; Fava M
J Clin Psychiatry; 2008 Aug; 69(8):1287-92. PubMed ID: 18605812
[TBL] [Abstract][Full Text] [Related]
7. A genome-wide association study of escitalopram treatment outcomes in patients with major depressive disorder.
Ren S; Peng H; Zhang J; Yang J; He Y; Sun Z; Wang G
Gene; 2024 Oct; 926():148596. PubMed ID: 38782219
[TBL] [Abstract][Full Text] [Related]
8. Baseline depression severity as a predictor of single and combination antidepressant treatment outcome: results from the CO-MED trial.
Friedman ES; Davis LL; Zisook S; Wisniewski SR; Trivedi MH; Fava M; Rush AJ;
Eur Neuropsychopharmacol; 2012 Mar; 22(3):183-99. PubMed ID: 21920711
[TBL] [Abstract][Full Text] [Related]
9. The impact of chronic depression on acute and long-term outcomes in a randomized trial comparing selective serotonin reuptake inhibitor monotherapy versus each of 2 different antidepressant medication combinations.
Sung SC; Haley CL; Wisniewski SR; Fava M; Nierenberg AA; Warden D; Morris DW; Kurian BT; Trivedi MH; Rush AJ;
J Clin Psychiatry; 2012 Jul; 73(7):967-76. PubMed ID: 22687487
[TBL] [Abstract][Full Text] [Related]
10. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
[TBL] [Abstract][Full Text] [Related]
11. Does negative affectivity predict differential response to an SSRI versus a non-SSRI antidepressant?
Gerra ML; Marchesi C; Amat JA; Blier P; Hellerstein DJ; Stewart JW
J Clin Psychiatry; 2014 Sep; 75(9):e939-44. PubMed ID: 25295437
[TBL] [Abstract][Full Text] [Related]
12. Resolution of sleepiness and fatigue in major depressive disorder: A comparison of bupropion and the selective serotonin reuptake inhibitors.
Papakostas GI; Nutt DJ; Hallett LA; Tucker VL; Krishen A; Fava M
Biol Psychiatry; 2006 Dec; 60(12):1350-5. PubMed ID: 16934768
[TBL] [Abstract][Full Text] [Related]
13. An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder.
Leuchter AF; Lesser IM; Trivedi MH; Rush AJ; Morris DW; Warden D; Fava M; Wisniewski SR; Luther JF; Perales M; Gaynes BN; Stewart JW
J Psychiatr Pract; 2008 Sep; 14(5):271-80. PubMed ID: 18832958
[TBL] [Abstract][Full Text] [Related]
14. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
Clayton AH; Croft HA; Horrigan JP; Wightman DS; Krishen A; Richard NE; Modell JG
J Clin Psychiatry; 2006 May; 67(5):736-46. PubMed ID: 16841623
[TBL] [Abstract][Full Text] [Related]
15. Medication augmentation after the failure of SSRIs for depression.
Trivedi MH; Fava M; Wisniewski SR; Thase ME; Quitkin F; Warden D; Ritz L; Nierenberg AA; Lebowitz BD; Biggs MM; Luther JF; Shores-Wilson K; Rush AJ;
N Engl J Med; 2006 Mar; 354(12):1243-52. PubMed ID: 16554526
[TBL] [Abstract][Full Text] [Related]
16. Effects of bupropion augmentation in escitalopram-resistant patients with major depressive disorder: an open-label, naturalistic study.
Maron E; Eller T; Vasar V; Nutt DJ
J Clin Psychiatry; 2009 Jul; 70(7):1054-6. PubMed ID: 19653982
[No Abstract] [Full Text] [Related]
17. The relationship between antidepressant use and smoking cessation in pregnant women in treatment for substance abuse.
Chisolm MS; Brigham EP; Tuten M; Strain EC; Jones HE
Am J Drug Alcohol Abuse; 2010 Jan; 36(1):46-51. PubMed ID: 20141396
[TBL] [Abstract][Full Text] [Related]
18. Retrospective analysis of the health-care costs of bupropion sustained release in comparison with other antidepressants.
Poret AW; Neslusan C; Ricci JF; Wang S; Khan ZM; Kwong JW
Value Health; 2001; 4(5):362-9. PubMed ID: 11705126
[TBL] [Abstract][Full Text] [Related]
19. Can C-reactive protein inform antidepressant medication selection in depressed outpatients? Findings from the CO-MED trial.
Jha MK; Minhajuddin A; Gadad BS; Greer T; Grannemann B; Soyombo A; Mayes TL; Rush AJ; Trivedi MH
Psychoneuroendocrinology; 2017 Apr; 78():105-113. PubMed ID: 28187400
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Efficacy and Safety of Aripiprazole Versus Bupropion Augmentation in Patients With Major Depressive Disorder Unresponsive to Selective Serotonin Reuptake Inhibitors: A Randomized, Prospective, Open-Label Study.
Cheon EJ; Lee KH; Park YW; Lee JH; Koo BH; Lee SJ; Sung HM
J Clin Psychopharmacol; 2017 Apr; 37(2):193-199. PubMed ID: 28129308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
